Global Bioengineered Artificial Skin Market Growth 2022-2028

Publication Month: Dec 2022 | No. of Pages: 128 Published By: LP Information
Single User License: US $ 3660
Corporate User License: US $ 7320

The global market for Bioengineered Artificial Skin is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Bioengineered Artificial Skin market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Bioengineered Artificial Skin market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Bioengineered Artificial Skin market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Bioengineered Artificial Skin market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Bioengineered Artificial Skin players cover Allergan (AbbVie), AlloSource, Organogenesis, BD and Smith & Nephew, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Bioengineered Artificial Skin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Bioengineered Artificial Skin market, with both quantitative and qualitative data, to help readers understand how the Bioengineered Artificial Skin market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Bioengineered Artificial Skin market and forecasts the market size by Type (Allogeneic Acellular, Xenogeneic and Allogeneic Cells), by Application (Hospitals, Specialty Clinics and Wound Care Centers,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Allogeneic Acellular
Xenogeneic
Allogeneic Cells
Autologous
Segmentation by application
Hospitals
Specialty Clinics
Wound Care Centers
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Allergan (AbbVie)
AlloSource
Organogenesis
BD
Smith & Nephew
Integra LifeSciences
Synthes (Johnson & Johnson)
Axogen
Vericel Corporation
LifeNet Health
MTF Biologics
Arthrex
Wright Medical Group NV (Stryker)
Cook Biotech Incorporated
Aroa Biosurgery
Surgalign Holdings
Anika Therapeutics
Forticell Bioscience
MLM Biologics
Promethean LifeSciences
Chapter Introduction
Chapter 1: Scope of Bioengineered Artificial Skin, Research Methodology, etc.
Chapter 2: Executive Summary, global Bioengineered Artificial Skin market size (sales and revenue) and CAGR, Bioengineered Artificial Skin market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Bioengineered Artificial Skin sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Bioengineered Artificial Skin sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Bioengineered Artificial Skin market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Allergan (AbbVie), AlloSource, Organogenesis, BD, Smith & Nephew, Integra LifeSciences, Synthes (Johnson & Johnson), Axogen and Vericel Corporation, etc.
Chapter 14: Research Findings and Conclusion

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bioengineered Artificial Skin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Bioengineered Artificial Skin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Bioengineered Artificial Skin by Country/Region, 2017, 2022 & 2028
2.2 Bioengineered Artificial Skin Segment by Type
2.2.1 Allogeneic Acellular
2.2.2 Xenogeneic
2.2.3 Allogeneic Cells
2.2.4 Autologous
2.3 Bioengineered Artificial Skin Sales by Type
2.3.1 Global Bioengineered Artificial Skin Sales Market Share by Type (2017-2022)
2.3.2 Global Bioengineered Artificial Skin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Bioengineered Artificial Skin Sale Price by Type (2017-2022)
2.4 Bioengineered Artificial Skin Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Wound Care Centers
2.5 Bioengineered Artificial Skin Sales by Application
2.5.1 Global Bioengineered Artificial Skin Sale Market Share by Application (2017-2022)
2.5.2 Global Bioengineered Artificial Skin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Bioengineered Artificial Skin Sale Price by Application (2017-2022)
3 Global Bioengineered Artificial Skin by Company
3.1 Global Bioengineered Artificial Skin Breakdown Data by Company
3.1.1 Global Bioengineered Artificial Skin Annual Sales by Company (2020-2022)
3.1.2 Global Bioengineered Artificial Skin Sales Market Share by Company (2020-2022)
3.2 Global Bioengineered Artificial Skin Annual Revenue by Company (2020-2022)
3.2.1 Global Bioengineered Artificial Skin Revenue by Company (2020-2022)
3.2.2 Global Bioengineered Artificial Skin Revenue Market Share by Company (2020-2022)
3.3 Global Bioengineered Artificial Skin Sale Price by Company
3.4 Key Manufacturers Bioengineered Artificial Skin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bioengineered Artificial Skin Product Location Distribution
3.4.2 Players Bioengineered Artificial Skin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bioengineered Artificial Skin by Geographic Region
4.1 World Historic Bioengineered Artificial Skin Market Size by Geographic Region (2017-2022)
4.1.1 Global Bioengineered Artificial Skin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Bioengineered Artificial Skin Annual Revenue by Geographic Region
4.2 World Historic Bioengineered Artificial Skin Market Size by Country/Region (2017-2022)
4.2.1 Global Bioengineered Artificial Skin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Bioengineered Artificial Skin Annual Revenue by Country/Region
4.3 Americas Bioengineered Artificial Skin Sales Growth
4.4 APAC Bioengineered Artificial Skin Sales Growth
4.5 Europe Bioengineered Artificial Skin Sales Growth
4.6 Middle East & Africa Bioengineered Artificial Skin Sales Growth
5 Americas
5.1 Americas Bioengineered Artificial Skin Sales by Country
5.1.1 Americas Bioengineered Artificial Skin Sales by Country (2017-2022)
5.1.2 Americas Bioengineered Artificial Skin Revenue by Country (2017-2022)
5.2 Americas Bioengineered Artificial Skin Sales by Type
5.3 Americas Bioengineered Artificial Skin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bioengineered Artificial Skin Sales by Region
6.1.1 APAC Bioengineered Artificial Skin Sales by Region (2017-2022)
6.1.2 APAC Bioengineered Artificial Skin Revenue by Region (2017-2022)
6.2 APAC Bioengineered Artificial Skin Sales by Type
6.3 APAC Bioengineered Artificial Skin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bioengineered Artificial Skin by Country
7.1.1 Europe Bioengineered Artificial Skin Sales by Country (2017-2022)
7.1.2 Europe Bioengineered Artificial Skin Revenue by Country (2017-2022)
7.2 Europe Bioengineered Artificial Skin Sales by Type
7.3 Europe Bioengineered Artificial Skin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bioengineered Artificial Skin by Country
8.1.1 Middle East & Africa Bioengineered Artificial Skin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Bioengineered Artificial Skin Revenue by Country (2017-2022)
8.2 Middle East & Africa Bioengineered Artificial Skin Sales by Type
8.3 Middle East & Africa Bioengineered Artificial Skin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bioengineered Artificial Skin
10.3 Manufacturing Process Analysis of Bioengineered Artificial Skin
10.4 Industry Chain Structure of Bioengineered Artificial Skin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bioengineered Artificial Skin Distributors
11.3 Bioengineered Artificial Skin Customer
12 World Forecast Review for Bioengineered Artificial Skin by Geographic Region
12.1 Global Bioengineered Artificial Skin Market Size Forecast by Region
12.1.1 Global Bioengineered Artificial Skin Forecast by Region (2023-2028)
12.1.2 Global Bioengineered Artificial Skin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bioengineered Artificial Skin Forecast by Type
12.7 Global Bioengineered Artificial Skin Forecast by Application
13 Key Players Analysis
13.1 Allergan (AbbVie)
13.1.1 Allergan (AbbVie) Company Information
13.1.2 Allergan (AbbVie) Bioengineered Artificial Skin Product Offered
13.1.3 Allergan (AbbVie) Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Allergan (AbbVie) Main Business Overview
13.1.5 Allergan (AbbVie) Latest Developments
13.2 AlloSource
13.2.1 AlloSource Company Information
13.2.2 AlloSource Bioengineered Artificial Skin Product Offered
13.2.3 AlloSource Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AlloSource Main Business Overview
13.2.5 AlloSource Latest Developments
13.3 Organogenesis
13.3.1 Organogenesis Company Information
13.3.2 Organogenesis Bioengineered Artificial Skin Product Offered
13.3.3 Organogenesis Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Organogenesis Main Business Overview
13.3.5 Organogenesis Latest Developments
13.4 BD
13.4.1 BD Company Information
13.4.2 BD Bioengineered Artificial Skin Product Offered
13.4.3 BD Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 BD Main Business Overview
13.4.5 BD Latest Developments
13.5 Smith & Nephew
13.5.1 Smith & Nephew Company Information
13.5.2 Smith & Nephew Bioengineered Artificial Skin Product Offered
13.5.3 Smith & Nephew Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Smith & Nephew Main Business Overview
13.5.5 Smith & Nephew Latest Developments
13.6 Integra LifeSciences
13.6.1 Integra LifeSciences Company Information
13.6.2 Integra LifeSciences Bioengineered Artificial Skin Product Offered
13.6.3 Integra LifeSciences Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Integra LifeSciences Main Business Overview
13.6.5 Integra LifeSciences Latest Developments
13.7 Synthes (Johnson & Johnson)
13.7.1 Synthes (Johnson & Johnson) Company Information
13.7.2 Synthes (Johnson & Johnson) Bioengineered Artificial Skin Product Offered
13.7.3 Synthes (Johnson & Johnson) Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Synthes (Johnson & Johnson) Main Business Overview
13.7.5 Synthes (Johnson & Johnson) Latest Developments
13.8 Axogen
13.8.1 Axogen Company Information
13.8.2 Axogen Bioengineered Artificial Skin Product Offered
13.8.3 Axogen Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Axogen Main Business Overview
13.8.5 Axogen Latest Developments
13.9 Vericel Corporation
13.9.1 Vericel Corporation Company Information
13.9.2 Vericel Corporation Bioengineered Artificial Skin Product Offered
13.9.3 Vericel Corporation Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Vericel Corporation Main Business Overview
13.9.5 Vericel Corporation Latest Developments
13.10 LifeNet Health
13.10.1 LifeNet Health Company Information
13.10.2 LifeNet Health Bioengineered Artificial Skin Product Offered
13.10.3 LifeNet Health Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 LifeNet Health Main Business Overview
13.10.5 LifeNet Health Latest Developments
13.11 MTF Biologics
13.11.1 MTF Biologics Company Information
13.11.2 MTF Biologics Bioengineered Artificial Skin Product Offered
13.11.3 MTF Biologics Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 MTF Biologics Main Business Overview
13.11.5 MTF Biologics Latest Developments
13.12 Arthrex
13.12.1 Arthrex Company Information
13.12.2 Arthrex Bioengineered Artificial Skin Product Offered
13.12.3 Arthrex Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Arthrex Main Business Overview
13.12.5 Arthrex Latest Developments
13.13 Wright Medical Group NV (Stryker)
13.13.1 Wright Medical Group NV (Stryker) Company Information
13.13.2 Wright Medical Group NV (Stryker) Bioengineered Artificial Skin Product Offered
13.13.3 Wright Medical Group NV (Stryker) Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Wright Medical Group NV (Stryker) Main Business Overview
13.13.5 Wright Medical Group NV (Stryker) Latest Developments
13.14 Cook Biotech Incorporated
13.14.1 Cook Biotech Incorporated Company Information
13.14.2 Cook Biotech Incorporated Bioengineered Artificial Skin Product Offered
13.14.3 Cook Biotech Incorporated Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Cook Biotech Incorporated Main Business Overview
13.14.5 Cook Biotech Incorporated Latest Developments
13.15 Aroa Biosurgery
13.15.1 Aroa Biosurgery Company Information
13.15.2 Aroa Biosurgery Bioengineered Artificial Skin Product Offered
13.15.3 Aroa Biosurgery Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Aroa Biosurgery Main Business Overview
13.15.5 Aroa Biosurgery Latest Developments
13.16 Surgalign Holdings
13.16.1 Surgalign Holdings Company Information
13.16.2 Surgalign Holdings Bioengineered Artificial Skin Product Offered
13.16.3 Surgalign Holdings Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Surgalign Holdings Main Business Overview
13.16.5 Surgalign Holdings Latest Developments
13.17 Anika Therapeutics
13.17.1 Anika Therapeutics Company Information
13.17.2 Anika Therapeutics Bioengineered Artificial Skin Product Offered
13.17.3 Anika Therapeutics Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Anika Therapeutics Main Business Overview
13.17.5 Anika Therapeutics Latest Developments
13.18 Forticell Bioscience
13.18.1 Forticell Bioscience Company Information
13.18.2 Forticell Bioscience Bioengineered Artificial Skin Product Offered
13.18.3 Forticell Bioscience Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Forticell Bioscience Main Business Overview
13.18.5 Forticell Bioscience Latest Developments
13.19 MLM Biologics
13.19.1 MLM Biologics Company Information
13.19.2 MLM Biologics Bioengineered Artificial Skin Product Offered
13.19.3 MLM Biologics Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 MLM Biologics Main Business Overview
13.19.5 MLM Biologics Latest Developments
13.20 Promethean LifeSciences
13.20.1 Promethean LifeSciences Company Information
13.20.2 Promethean LifeSciences Bioengineered Artificial Skin Product Offered
13.20.3 Promethean LifeSciences Bioengineered Artificial Skin Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Promethean LifeSciences Main Business Overview
13.20.5 Promethean LifeSciences Latest Developments
14 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Bioengineered Artificial Skin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Bioengineered Artificial Skin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Allogeneic Acellular
Table 4. Major Players of Xenogeneic
Table 5. Major Players of Allogeneic Cells
Table 6. Major Players of Autologous
Table 7. Global Bioengineered Artificial Skin Sales by Type (2017-2022) & (K Units)
Table 8. Global Bioengineered Artificial Skin Sales Market Share by Type (2017-2022)
Table 9. Global Bioengineered Artificial Skin Revenue by Type (2017-2022) & ($ million)
Table 10. Global Bioengineered Artificial Skin Revenue Market Share by Type (2017-2022)
Table 11. Global Bioengineered Artificial Skin Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Bioengineered Artificial Skin Sales by Application (2017-2022) & (K Units)
Table 13. Global Bioengineered Artificial Skin Sales Market Share by Application (2017-2022)
Table 14. Global Bioengineered Artificial Skin Revenue by Application (2017-2022)
Table 15. Global Bioengineered Artificial Skin Revenue Market Share by Application (2017-2022)
Table 16. Global Bioengineered Artificial Skin Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Bioengineered Artificial Skin Sales by Company (2020-2022) & (K Units)
Table 18. Global Bioengineered Artificial Skin Sales Market Share by Company (2020-2022)
Table 19. Global Bioengineered Artificial Skin Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Bioengineered Artificial Skin Revenue Market Share by Company (2020-2022)
Table 21. Global Bioengineered Artificial Skin Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Bioengineered Artificial Skin Producing Area Distribution and Sales Area
Table 23. Players Bioengineered Artificial Skin Products Offered
Table 24. Bioengineered Artificial Skin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Bioengineered Artificial Skin Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Bioengineered Artificial Skin Sales Market Share Geographic Region (2017-2022)
Table 29. Global Bioengineered Artificial Skin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Bioengineered Artificial Skin Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Bioengineered Artificial Skin Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Bioengineered Artificial Skin Sales Market Share by Country/Region (2017-2022)
Table 33. Global Bioengineered Artificial Skin Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Bioengineered Artificial Skin Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Bioengineered Artificial Skin Sales by Country (2017-2022) & (K Units)
Table 36. Americas Bioengineered Artificial Skin Sales Market Share by Country (2017-2022)
Table 37. Americas Bioengineered Artificial Skin Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Bioengineered Artificial Skin Revenue Market Share by Country (2017-2022)
Table 39. Americas Bioengineered Artificial Skin Sales by Type (2017-2022) & (K Units)
Table 40. Americas Bioengineered Artificial Skin Sales Market Share by Type (2017-2022)
Table 41. Americas Bioengineered Artificial Skin Sales by Application (2017-2022) & (K Units)
Table 42. Americas Bioengineered Artificial Skin Sales Market Share by Application (2017-2022)
Table 43. APAC Bioengineered Artificial Skin Sales by Region (2017-2022) & (K Units)
Table 44. APAC Bioengineered Artificial Skin Sales Market Share by Region (2017-2022)
Table 45. APAC Bioengineered Artificial Skin Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Bioengineered Artificial Skin Revenue Market Share by Region (2017-2022)
Table 47. APAC Bioengineered Artificial Skin Sales by Type (2017-2022) & (K Units)
Table 48. APAC Bioengineered Artificial Skin Sales Market Share by Type (2017-2022)
Table 49. APAC Bioengineered Artificial Skin Sales by Application (2017-2022) & (K Units)
Table 50. APAC Bioengineered Artificial Skin Sales Market Share by Application (2017-2022)
Table 51. Europe Bioengineered Artificial Skin Sales by Country (2017-2022) & (K Units)
Table 52. Europe Bioengineered Artificial Skin Sales Market Share by Country (2017-2022)
Table 53. Europe Bioengineered Artificial Skin Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Bioengineered Artificial Skin Revenue Market Share by Country (2017-2022)
Table 55. Europe Bioengineered Artificial Skin Sales by Type (2017-2022) & (K Units)
Table 56. Europe Bioengineered Artificial Skin Sales Market Share by Type (2017-2022)
Table 57. Europe Bioengineered Artificial Skin Sales by Application (2017-2022) & (K Units)
Table 58. Europe Bioengineered Artificial Skin Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Bioengineered Artificial Skin Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Bioengineered Artificial Skin Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Bioengineered Artificial Skin Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Bioengineered Artificial Skin Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Bioengineered Artificial Skin Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Bioengineered Artificial Skin Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Bioengineered Artificial Skin Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Bioengineered Artificial Skin Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Bioengineered Artificial Skin
Table 68. Key Market Challenges & Risks of Bioengineered Artificial Skin
Table 69. Key Industry Trends of Bioengineered Artificial Skin
Table 70. Bioengineered Artificial Skin Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Bioengineered Artificial Skin Distributors List
Table 73. Bioengineered Artificial Skin Customer List
Table 74. Global Bioengineered Artificial Skin Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Bioengineered Artificial Skin Sales Market Forecast by Region
Table 76. Global Bioengineered Artificial Skin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Bioengineered Artificial Skin Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Bioengineered Artificial Skin Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Bioengineered Artificial Skin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Bioengineered Artificial Skin Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Bioengineered Artificial Skin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Bioengineered Artificial Skin Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Bioengineered Artificial Skin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Bioengineered Artificial Skin Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Bioengineered Artificial Skin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Bioengineered Artificial Skin Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Bioengineered Artificial Skin Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Bioengineered Artificial Skin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Bioengineered Artificial Skin Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Bioengineered Artificial Skin Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Bioengineered Artificial Skin Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Bioengineered Artificial Skin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Bioengineered Artificial Skin Revenue Market Share Forecast by Application (2023-2028)
Table 94. Allergan (AbbVie) Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 95. Allergan (AbbVie) Bioengineered Artificial Skin Product Offered
Table 96. Allergan (AbbVie) Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Allergan (AbbVie) Main Business
Table 98. Allergan (AbbVie) Latest Developments
Table 99. AlloSource Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 100. AlloSource Bioengineered Artificial Skin Product Offered
Table 101. AlloSource Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. AlloSource Main Business
Table 103. AlloSource Latest Developments
Table 104. Organogenesis Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 105. Organogenesis Bioengineered Artificial Skin Product Offered
Table 106. Organogenesis Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Organogenesis Main Business
Table 108. Organogenesis Latest Developments
Table 109. BD Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 110. BD Bioengineered Artificial Skin Product Offered
Table 111. BD Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. BD Main Business
Table 113. BD Latest Developments
Table 114. Smith & Nephew Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 115. Smith & Nephew Bioengineered Artificial Skin Product Offered
Table 116. Smith & Nephew Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Smith & Nephew Main Business
Table 118. Smith & Nephew Latest Developments
Table 119. Integra LifeSciences Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 120. Integra LifeSciences Bioengineered Artificial Skin Product Offered
Table 121. Integra LifeSciences Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Integra LifeSciences Main Business
Table 123. Integra LifeSciences Latest Developments
Table 124. Synthes (Johnson & Johnson) Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 125. Synthes (Johnson & Johnson) Bioengineered Artificial Skin Product Offered
Table 126. Synthes (Johnson & Johnson) Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Synthes (Johnson & Johnson) Main Business
Table 128. Synthes (Johnson & Johnson) Latest Developments
Table 129. Axogen Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 130. Axogen Bioengineered Artificial Skin Product Offered
Table 131. Axogen Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Axogen Main Business
Table 133. Axogen Latest Developments
Table 134. Vericel Corporation Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 135. Vericel Corporation Bioengineered Artificial Skin Product Offered
Table 136. Vericel Corporation Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Vericel Corporation Main Business
Table 138. Vericel Corporation Latest Developments
Table 139. LifeNet Health Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 140. LifeNet Health Bioengineered Artificial Skin Product Offered
Table 141. LifeNet Health Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. LifeNet Health Main Business
Table 143. LifeNet Health Latest Developments
Table 144. MTF Biologics Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 145. MTF Biologics Bioengineered Artificial Skin Product Offered
Table 146. MTF Biologics Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. MTF Biologics Main Business
Table 148. MTF Biologics Latest Developments
Table 149. Arthrex Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 150. Arthrex Bioengineered Artificial Skin Product Offered
Table 151. Arthrex Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. Arthrex Main Business
Table 153. Arthrex Latest Developments
Table 154. Wright Medical Group NV (Stryker) Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 155. Wright Medical Group NV (Stryker) Bioengineered Artificial Skin Product Offered
Table 156. Wright Medical Group NV (Stryker) Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. Wright Medical Group NV (Stryker) Main Business
Table 158. Wright Medical Group NV (Stryker) Latest Developments
Table 159. Cook Biotech Incorporated Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 160. Cook Biotech Incorporated Bioengineered Artificial Skin Product Offered
Table 161. Cook Biotech Incorporated Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 162. Cook Biotech Incorporated Main Business
Table 163. Cook Biotech Incorporated Latest Developments
Table 164. Aroa Biosurgery Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 165. Aroa Biosurgery Bioengineered Artificial Skin Product Offered
Table 166. Aroa Biosurgery Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 167. Aroa Biosurgery Main Business
Table 168. Aroa Biosurgery Latest Developments
Table 169. Surgalign Holdings Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 170. Surgalign Holdings Bioengineered Artificial Skin Product Offered
Table 171. Surgalign Holdings Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 172. Surgalign Holdings Main Business
Table 173. Surgalign Holdings Latest Developments
Table 174. Anika Therapeutics Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 175. Anika Therapeutics Bioengineered Artificial Skin Product Offered
Table 176. Anika Therapeutics Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 177. Anika Therapeutics Main Business
Table 178. Anika Therapeutics Latest Developments
Table 179. Forticell Bioscience Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 180. Forticell Bioscience Bioengineered Artificial Skin Product Offered
Table 181. Forticell Bioscience Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 182. Forticell Bioscience Main Business
Table 183. Forticell Bioscience Latest Developments
Table 184. MLM Biologics Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 185. MLM Biologics Bioengineered Artificial Skin Product Offered
Table 186. MLM Biologics Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 187. MLM Biologics Main Business
Table 188. MLM Biologics Latest Developments
Table 189. Promethean LifeSciences Basic Information, Bioengineered Artificial Skin Manufacturing Base, Sales Area and Its Competitors
Table 190. Promethean LifeSciences Bioengineered Artificial Skin Product Offered
Table 191. Promethean LifeSciences Bioengineered Artificial Skin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 192. Promethean LifeSciences Main Business
Table 193. Promethean LifeSciences Latest Developments
List of Figures
Figure 1. Picture of Bioengineered Artificial Skin
Figure 2. Bioengineered Artificial Skin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bioengineered Artificial Skin Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Bioengineered Artificial Skin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Bioengineered Artificial Skin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Allogeneic Acellular
Figure 10. Product Picture of Xenogeneic
Figure 11. Product Picture of Allogeneic Cells
Figure 12. Product Picture of Autologous
Figure 13. Global Bioengineered Artificial Skin Sales Market Share by Type in 2021
Figure 14. Global Bioengineered Artificial Skin Revenue Market Share by Type (2017-2022)
Figure 15. Bioengineered Artificial Skin Consumed in Hospitals
Figure 16. Global Bioengineered Artificial Skin Market: Hospitals (2017-2022) & (K Units)
Figure 17. Bioengineered Artificial Skin Consumed in Specialty Clinics
Figure 18. Global Bioengineered Artificial Skin Market: Specialty Clinics (2017-2022) & (K Units)
Figure 19. Bioengineered Artificial Skin Consumed in Wound Care Centers
Figure 20. Global Bioengineered Artificial Skin Market: Wound Care Centers (2017-2022) & (K Units)
Figure 21. Global Bioengineered Artificial Skin Sales Market Share by Application (2017-2022)
Figure 22. Global Bioengineered Artificial Skin Revenue Market Share by Application in 2021
Figure 23. Bioengineered Artificial Skin Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Bioengineered Artificial Skin Revenue Market Share by Company in 2021
Figure 25. Global Bioengineered Artificial Skin Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Bioengineered Artificial Skin Revenue Market Share by Geographic Region in 2021
Figure 27. Global Bioengineered Artificial Skin Sales Market Share by Region (2017-2022)
Figure 28. Global Bioengineered Artificial Skin Revenue Market Share by Country/Region in 2021
Figure 29. Americas Bioengineered Artificial Skin Sales 2017-2022 (K Units)
Figure 30. Americas Bioengineered Artificial Skin Revenue 2017-2022 ($ Millions)
Figure 31. APAC Bioengineered Artificial Skin Sales 2017-2022 (K Units)
Figure 32. APAC Bioengineered Artificial Skin Revenue 2017-2022 ($ Millions)
Figure 33. Europe Bioengineered Artificial Skin Sales 2017-2022 (K Units)
Figure 34. Europe Bioengineered Artificial Skin Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Bioengineered Artificial Skin Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Bioengineered Artificial Skin Revenue 2017-2022 ($ Millions)
Figure 37. Americas Bioengineered Artificial Skin Sales Market Share by Country in 2021
Figure 38. Americas Bioengineered Artificial Skin Revenue Market Share by Country in 2021
Figure 39. United States Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Bioengineered Artificial Skin Sales Market Share by Region in 2021
Figure 44. APAC Bioengineered Artificial Skin Revenue Market Share by Regions in 2021
Figure 45. China Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Bioengineered Artificial Skin Sales Market Share by Country in 2021
Figure 52. Europe Bioengineered Artificial Skin Revenue Market Share by Country in 2021
Figure 53. Germany Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Bioengineered Artificial Skin Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Bioengineered Artificial Skin Revenue Market Share by Country in 2021
Figure 60. Egypt Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Bioengineered Artificial Skin Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Bioengineered Artificial Skin in 2021
Figure 66. Manufacturing Process Analysis of Bioengineered Artificial Skin
Figure 67. Industry Chain Structure of Bioengineered Artificial Skin
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets